Antiadhesive natural products against uropathogenic E. coli: What can we learn from cranberry extract?


Journal

Journal of ethnopharmacology
ISSN: 1872-7573
Titre abrégé: J Ethnopharmacol
Pays: Ireland
ID NLM: 7903310

Informations de publication

Date de publication:
15 Jul 2020
Historique:
received: 03 02 2020
revised: 14 04 2020
accepted: 14 04 2020
pubmed: 21 4 2020
medline: 25 2 2021
entrez: 21 4 2020
Statut: ppublish

Résumé

Extracts from Cranberry fruits (Vaccinium macrocarpon) are traditionally used against urinary tract infections, mainly due to antiadhesive activity against uropathogenic E. coli (UPEC), but the exact mode of action and compounds, responsible for the activity, are unknown. i. To investigate if cranberry extract acts only by a single component or must be assessed as a multi-active-compound preparation; ii to screen isolated cranberry-related natural products under in vitro conditions to pinpoint natural products with antiadhesive effects against UPEC, followed by in silico calculations (QSAR) to predict potential antiadhesive compounds; iii. investigations by using urine samples from cranberry treated volunteers for evaluation on the bacterial transcriptome and the mannose-binding side of FimH, iv. to investigate if besides Tamm Horsfall Protein induction in the kidney, the extract acts also directly against UPEC. Antiadhesive activity of 105 compounds was determined by flow cytometric adhesion assay (UPEC UTI89 on T24 bladder cells). Urine samples from 16 volunteers treated with cranberry extract (p.o., 7 days, 900 mg/day) were used for ex vivo testing concerning influence on the bacterial transcriptome (Illumina RNA-seq) and interaction with the mannose binding domain of type-1 fimbriae. i. The antiadhesive effect of cranberry extract cannot be attributed to a single compound or to a single fraction. ii. Unglycosylated flavones and flavonols with bulky substitution of the B ring contribute to the antiadhesive activity. 3'-8″-biflavones and flavolignans (not related to cranberry fruits) were identified as potent antiadhesive compounds against UPEC. iii. QSAR yielded a model with good statistical performance and sufficient internal and external predictive ability. iv. Urine samples from male cranberry-treated volunteers indicated significant interaction with the mannose binding domain of type-1 fimbriae, which correlated with the amount of Tamm-Horsfall Protein in the test samples. v Cranberry extract did not influence the UPEC transcriptome; gene expression of bacterial adhesins (P-, S-fimbrae, curli) was not influenced by the urine samples, while a slight, but non-significant upregulation of type 1 fimbriae was observed. B-ring substituted flavones and flavonols from cranberry contribute to the antiadhesive activity against UPEC by inhibition of the FimH-mediated interaction with the host cell bladder epithelium.

Identifiants

pubmed: 32311481
pii: S0378-8741(20)30487-6
doi: 10.1016/j.jep.2020.112889
pii:
doi:

Substances chimiques

Adhesins, Escherichia coli 0
Anti-Bacterial Agents 0
Plant Extracts 0
UMOD protein, human 0
Uromodulin 0
fimH protein, E coli 0
Fimbriae Proteins 147680-16-8

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

112889

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.

Auteurs

Birte Scharf (B)

University of Münster, Institute of Pharmaceutical Biology and Phytochemistry, Münster, Germany.

Thomas J Schmidt (TJ)

University of Münster, Institute of Pharmaceutical Biology and Phytochemistry, Münster, Germany.

Said Rabbani (S)

University of Basel, Department Pharmaceutical Sciences, Molecular Pharmacy, Basel, Switzerland.

Christoph Stork (C)

University Hospital Münster, Institute of Hygiene, Münster, Germany.

Ulrich Dobrindt (U)

University Hospital Münster, Institute of Hygiene, Münster, Germany.

Jandirk Sendker (J)

University of Münster, Institute of Pharmaceutical Biology and Phytochemistry, Münster, Germany.

Beat Ernst (B)

University of Basel, Department Pharmaceutical Sciences, Molecular Pharmacy, Basel, Switzerland.

Andreas Hensel (A)

University of Münster, Institute of Pharmaceutical Biology and Phytochemistry, Münster, Germany. Electronic address: ahensel@uni-muenster.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH